Important observations All five clinical trials that were included in the analysis reported GLP-1 receptor agonist-mediated reduction in substance use disorder, with two trials respectively reporting a significant therapeutic impact of GLP-1 receptor agonist in reducing alcohol use disorder and nicotine use disorder
Safety and Tolerability Tirzepatide slows gastric emptying, which can influence the absorption of other oral medications
Some patients get approved based solely on questionnaire responses, while others must complete blood work
Reduced caloric intake lowers the availability of amino acid precursors needed for serotonin and GABA production, both of which promote calm and sleep
The expression of MOTS-c is age-dependent and has been detected in multiple tissues, including skeletal muscle, T cells and in systemic circulation 6,7,8,9,10 and the pancreas 7,11